A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma.
Zhu W, Zhang Z, Chen J, Chen X, Huang L, Zhang X, Huang X, Ma N, Xu W, Yi X, Lu X, Fu X, Li S, Mo G, Wang Y, Yuan G, Zang M, Li Q, Jiang X, He Y, Wu S, He Y, Li Y, Hou J.
Zhu W, et al. Among authors: yi x.
Signal Transduct Target Ther. 2024 Apr 20;9(1):101. doi: 10.1038/s41392-024-01792-6.
Signal Transduct Target Ther. 2024.
PMID: 38643203
Free PMC article.